CN
Drug Modalities
Technical Solutions
ESG
Newsroom
About Us
Contact Us
CN
CN
Home/Newsroom/News

News 2024-12-19

Porton Newsletter | Q4 2024 Recap

Porton Expands GMP Manufacturing and New Modality Services in Shanghai Fengxian

Porton Successfully Hosts Ceremony for New Modality Capacity Upgrade

Drug Modalities: Innovative Services & Solutions from Porton Pharma


Click to Download

Others
More

News 2026-10-24

Porton Shared Complex Bioconjugate Development Strategies at the 17th World ADC San Diego

As a conference partner, Porton contributed a scientific presentation and poster addressing the technical challenges of developing ADCs and emerging bioconjugates.

News 2026-10-22

Simplifying Synthesis with Radical Cross-Coupling: Prof. Phil S. Baran of Scripps Research Lectures at Porton

The event was hosted by Dr. Yongli Zhong, CSO, and attended by Mr. Oliver Ju, Chairman and CEO; Mr. Yunxing Yin, VP and Head of the Small Molecule Platform, and more than 200 R&D and technical staff.
Become part of Porton's community to access personalized insights and resources.
Subscribe to the Newsletter
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.
US: (609) 860-1300
CN: (86) 23-8608-3200

ⓒ 2026 PORTON Legal Disclaimer| Privacy & Cookie Policy


This website contains product information intended for different regions and may include details that are not available or authorized in your country. Please be aware that we assume no responsibility for any access to such information that may contravene applicable laws, regulations, or usage restrictions in your jurisdiction.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

ⓒ 2026 PORTON Legal Disclaimer| Privacy & Cookie Policy


US: (609) 860-1300
CN: (86) 23-8608-3200